Scancell Holdings PLC. (SCNLF)

[Blue Fire]

TWO KEY NOTES

There are two key notes playing in the background here. Increasing buying momentum and a M&A climate where a bid could come for Scancell at any moment.

The big pharmas are on a buying spree as their patents expire and their IP pantries get ever emptier. Scancell is a prime target, ticking those golden boxes of immunotherapy and cancer vaccines, where the industry's future income streams will flow the strongest.

In the almost daily announcement of new deals the big boys aren't even waiting for Phase 2 to finish. Its billion dollar deal after billion dollar deal.

The savvy punter will be smelling the confetti of banknotes on the breeze and buying now before the check made out to Scancell gets signed, sealed and delivered.